Verisol Collagen Peptides for Wrinkle Reduction
Based on the highest-quality independent evidence, there is currently no clinical support for using Verisol or other collagen peptide supplements to reduce wrinkles, as industry-funded studies show benefit while independent studies reveal no effect.
Critical Evidence Quality Assessment
The most recent and rigorous systematic review fundamentally challenges the efficacy claims:
A 2025 meta-analysis of 23 randomized controlled trials (1474 participants) published in The American Journal of Medicine found that studies NOT funded by pharmaceutical companies showed NO effect of collagen supplements on skin hydration, elasticity, or wrinkles 1.
In contrast, studies receiving pharmaceutical company funding demonstrated significant effects, revealing substantial funding bias in the collagen supplement literature 1.
High-quality studies showed no significant improvement in any skin parameter, while only low-quality studies demonstrated benefits 1.
Industry-Funded Evidence (Lower Reliability)
While multiple industry-sponsored trials report positive outcomes, these must be interpreted cautiously given the systematic funding bias:
A 2014 double-blind study of 114 women (ages 45-65) receiving 2.5g daily Verisol® for 8 weeks showed 20% reduction in eye wrinkle volume and increased procollagen I (65%) and elastin (18%) synthesis 2.
A 2026 trial with 119 women (ages 35-55) using 10g daily collagen peptides demonstrated reduced wrinkle number and length, plus elevated TGF-β and Klotho levels 3.
Additional studies from 2018-2024 consistently report improvements in skin hydration, elasticity, and wrinkles with various collagen formulations 4, 5, 6.
Clinical Recommendation Algorithm
For patients seeking wrinkle reduction, recommend evidence-based alternatives with independent validation:
First-line: FDA-approved topical treatments (tretinoin, retinoids) with established efficacy independent of industry funding.
Second-line: Chemical peels using trichloroacetic acid 3.75% + lactic acid 15%, which achieve excellent improvement in 38% of patients and fair-to-excellent improvement in 93-97% for periorbital wrinkles 7.
Third-line: PRP/PRF-based treatments combined with non-crosslinked hyaluronic acid, showing 20-24% improvement in FACE-Q scores according to independent guideline assessments 8.
Critical Pitfalls to Avoid
Do not recommend collagen supplements based solely on industry-funded research, as the 2025 meta-analysis demonstrates systematic bias when pharmaceutical companies fund studies 1.
Patients should understand that visible collagen-remodeling results require several months of consistent treatment with validated therapies, not oral supplements 7.
The FDA drug label information provided references verapamil (a calcium channel blocker), not Verisol collagen peptides, indicating no FDA-approved therapeutic claims exist for Verisol in wrinkle treatment 9.